Dipna Pharmachem [DPL] vs Sastasundar Ventures [SASTASUNDR] Detailed Stock Comparison

Dipna Pharmachem

BSE

Sastasundar Ventures

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dipna Pharmachem wins in 11 metrics, Sastasundar Ventures wins in 6 metrics, with 0 ties. Dipna Pharmachem appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Dipna Pharmachem	Sastasundar Ventures	Better
P/E Ratio (TTM)	55.73	24.05	Sastasundar Ventures
Price-to-Book Ratio	1.39	1.38	Sastasundar Ventures
Debt-to-Equity Ratio	44.74	0.11	Sastasundar Ventures
PEG Ratio	N/A	-0.02	N/A
EV/EBITDA	20.51	289.64	Dipna Pharmachem
Profit Margin (TTM)	0.78%	-7.79%	Dipna Pharmachem
Operating Margin (TTM)	5.69%	-1.59%	Dipna Pharmachem
EBITDA Margin (TTM)	5.69%	N/A	N/A
Return on Equity	2.56%	-14.33%	Dipna Pharmachem
Return on Assets (TTM)	1.61%	-0.12%	Dipna Pharmachem
Free Cash Flow (TTM)	$-92.15M	$-276.65M	Dipna Pharmachem
Dividend Yield	23.16%	N/A	N/A
1-Year Return	-94.60%	-6.91%	Sastasundar Ventures
Price-to-Sales Ratio (TTM)	0.45	0.79	Dipna Pharmachem
Enterprise Value	$704.19M	$11.05B	Sastasundar Ventures
EV/Revenue Ratio	0.56	0.94	Dipna Pharmachem
Gross Profit Margin (TTM)	44.45%	5.97%	Dipna Pharmachem
Revenue per Share (TTM)	$53	$368	Sastasundar Ventures
Earnings per Share (Diluted)	$0.41	$-28.67	Dipna Pharmachem
Beta (Stock Volatility)	-0.21	0.62	Dipna Pharmachem

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Dipna Pharmachem vs Sastasundar Ventures Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Dipna Pharmachem	-0.17%	-1.90%	5.17%	5.78%	74.72%	62.99%
Sastasundar Ventures	-0.74%	0.09%	-2.37%	14.69%	3.70%	-8.78%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Dipna Pharmachem	-94.60%	-88.33%	-54.14%	-78.61%	-79.07%	-79.07%
Sastasundar Ventures	-6.91%	-0.65%	212.17%	166.77%	182.09%	182.09%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Dipna Pharmachem (DPL): View Full Stock Overview

Sastasundar Ventures (SASTASUNDR): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Dipna Pharmachem vs Sastasundar Ventures

Metric	DPL	SASTASUNDR
Market Information
Market Cap i	₹564.97M	₹9.22B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	44,400	18,584
90 Day Avg. Volume i	82,700	16,990
Last Close	₹23.78	₹289.85
52 Week Range	₹11.45 - ₹542.55	₹205.00 - ₹381.70
% from 52W High	-95.62%	-24.06%
All-Time High	₹558.00 (Jan 29, 2024)	₹580.00 (Jan 10, 2022)
% from All-Time High	-95.74%	-50.03%
Growth Metrics
Quarterly Revenue Growth	-0.62%	-0.04%
Quarterly Earnings Growth	0.29%	-0.17%
Financial Health
Profit Margin (TTM) i	0.01%	-0.08%
Operating Margin (TTM) i	0.06%	-0.02%
Return on Equity (TTM) i	0.03%	-0.14%
Debt to Equity (MRQ) i	44.74	0.11
Cash & Liquidity
Book Value per Share (MRQ)	₹16.40	₹210.68
Cash per Share (MRQ)	₹0.18	₹3.91
Operating Cash Flow (TTM) i	₹-91,946,000	₹-173,086,000
Levered Free Cash Flow (TTM) i	₹-123,409,000	₹595.87M
Dividends
Last 12-Month Dividend Yield i	23.16%	N/A
Last 12-Month Dividend i	₹5.00	₹0.00

Valuation & Enterprise Metrics Analysis: Dipna Pharmachem vs Sastasundar Ventures

Metric	DPL	SASTASUNDR
Price Ratios
P/E Ratio (TTM) i	55.73	24.05
Forward P/E i	N/A	-16.47
PEG Ratio i	N/A	-0.02
Price to Sales (TTM) i	0.45	0.79
Price to Book (MRQ) i	1.39	1.38
Market Capitalization
Market Capitalization i	₹564.97M	₹9.22B
Enterprise Value i	₹704.19M	₹11.05B
Enterprise Value Metrics
Enterprise to Revenue i	0.56	0.94
Enterprise to EBITDA i	20.51	289.64
Risk & Other Metrics
Beta i	-0.21	0.62
Book Value per Share (MRQ) i	₹16.40	₹210.68

Financial Statements Comparison: Dipna Pharmachem vs Sastasundar Ventures

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	DPL	SASTASUNDR
Revenue/Sales i	₹1.48B	₹2.82B
Cost of Goods Sold i	₹823.75M	₹2.65B
Gross Profit i	₹659.26M	₹168.34M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹362.82M	₹-302.40M
EBITDA i	₹1.44B	₹-72.76M
Pre-Tax Income i	₹1.13B	₹-46.35M
Income Tax i	₹455.55M	₹-222.07M
Net Income (Profit) i	₹676.72M	₹175.72M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	DPL	SASTASUNDR
Cash & Equivalents i	₹4.26M	₹124.22M
Total Current Assets i	₹1.32B	₹1.49B
Total Current Liabilities i	₹849.96M	₹641.60M
Long-Term Debt i	₹88.90M	₹9.19M
Total Shareholders Equity i	₹384.93M	₹8.65B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹459,000	₹633.66M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	DPL	SASTASUNDR
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	DPL	SASTASUNDR
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	44,400	18,584
Average Daily Volume (90 Day) i	82,700	16,990
Shares Outstanding i	24.05M	31.81M
Float Shares i	7.91M	6.31M
% Held by Insiders i	0.45%	0.79%
% Held by Institutions i	0.00%	0.01%

Dividend Analysis & Yield Comparison: Dipna Pharmachem vs Sastasundar Ventures

Metric	DPL	SASTASUNDR
Last 12-Month Dividend i	₹5.00	₹0.00
Last 12-Month Dividend Yield i	23.16%	N/A
3-Year Avg Annual Dividend i	₹6.00	₹0.00
3-Year Avg Dividend Yield i	1.72%	N/A
3-Year Total Dividends i	₹18.00	₹0.00
Ex-Dividend Date	Aug 13, 2024	N/A

Dipna Pharmachem [DPL] vs Sastasundar Ventures [SASTASUNDR] Detailed Stock Comparison